
64 patients with pain associated with advanced cancer were treated with either zzso or zzso as initial zzso Patients were randomly allocated to 1 of 4 treatment groups: oral zzso 300 zzso oral zzso 150 zzso zzso zzso 400 zzso and zzso zzso 200 zzso After 1 week of treatment, both drugs provided an adequate degree of pain relief and allowed an increase in sleep zzso There were no significant differences in efficacy between the drugs or routes of zzso Fewer side effects were observed with zzso giving this agent a better therapeutic index than the reference zzso 

